Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.

Dueregger A, Heidegger I, Ofer P, Perktold B, Ramoner R, Klocker H, Eder IE.

Nutrients. 2014 Oct 21;6(10):4491-519. doi: 10.3390/nu6104491.

PMID:
25338271
[PubMed - in process]
Free PMC Article
2.

Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.

Neeb A, Hefele S, Bormann S, Parson W, Adams F, Wolf P, Miernik A, Schoenthaler M, Kroenig M, Wilhelm K, Schultze-Seemann W, Nestel S, Schaefer G, Bu H, Klocker H, Nazarenko I, Cato AC.

Oncotarget. 2014 Sep 30;5(18):8681-9.

PMID:
25237833
[PubMed - in process]
Free PMC Article
3.

A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.

Köhler A, Demir U, Kickstein E, Krauss S, Aigner J, Aranda-Orgillés B, Karagiannidis AI, Achmüller C, Bu H, Wunderlich A, Schweiger MR, Schaefer G, Schweiger S, Klocker H, Schneider R.

Mol Cancer. 2014 Jun 9;13:146. doi: 10.1186/1476-4598-13-146.

PMID:
24913494
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.

Heidegger I, Kern J, Ofer P, Klocker H, Massoner P.

Oncotarget. 2014 May 15;5(9):2723-35.

PMID:
24809298
[PubMed - in process]
Free PMC Article
5.

Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.

Demir U, Koehler A, Schneider R, Schweiger S, Klocker H.

BMC Cancer. 2014 Jan 31;14:52. doi: 10.1186/1471-2407-14-52.

PMID:
24484909
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M.

Endocr Relat Cancer. 2014 Jan 30;21(2):175-87. doi: 10.1530/ERC-13-0446. Print 2014 Apr.

PMID:
24280133
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.

Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H.

J Steroid Biochem Mol Biol. 2013 Nov;138:248-56. doi: 10.1016/j.jsbmb.2013.06.002. Epub 2013 Jun 20. Review.

PMID:
23792785
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo.

Eder IE, Egger M, Neuwirt H, Seifarth C, Maddalo D, Desiniotis A, Schäfer G, Puhr M, Bektic J, Cato AC, Klocker H.

Int J Mol Sci. 2013 Jun 4;14(6):11942-62. doi: 10.3390/ijms140611942.

PMID:
23736698
[PubMed - in process]
Free PMC Article
9.

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.

Bruchmann A, Roller C, Walther TV, Schäfer G, Lehmusvaara S, Visakorpi T, Klocker H, Cato AC, Maddalo D.

BMC Cancer. 2013 Mar 1;13:96. doi: 10.1186/1471-2407-13-96.

PMID:
23448667
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.

Massoner P, Kugler KG, Unterberger K, Kuner R, Mueller LA, Fälth M, Schäfer G, Seifarth C, Ecker S, Verdorfer I, Graber A, Sültmann H, Klocker H.

PLoS One. 2013;8(2):e55207. doi: 10.1371/journal.pone.0055207. Epub 2013 Feb 4.

PMID:
23390522
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.

Schaefer G, Mosquera JM, Ramoner R, Park K, Romanel A, Steiner E, Horninger W, Bektic J, Ladurner-Rennau M, Rubin MA, Demichelis F, Klocker H.

Prostate Cancer Prostatic Dis. 2013 Jun;16(2):132-8. doi: 10.1038/pcan.2013.4. Epub 2013 Feb 5.

PMID:
23381693
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, Thompson IM.

World J Urol. 2014 Feb;32(1):185-91. doi: 10.1007/s00345-012-0869-2. Epub 2012 Apr 22.

PMID:
22527674
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.

Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6686-91. doi: 10.1073/pnas.1117405109. Epub 2012 Apr 10.

PMID:
22496589
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ.

World J Urol. 2012 Apr;30(2):181-7. doi: 10.1007/s00345-011-0818-5. Epub 2011 Dec 31.

PMID:
22210512
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Roobol MJ, Schröder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW.

World J Urol. 2012 Apr;30(2):149-55. doi: 10.1007/s00345-011-0804-y. Epub 2011 Dec 28.

PMID:
22203238
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients.

Zenzmaier C, Heitz M, Klocker H, Buck M, Gardiner RA, Berger P.

J Transl Med. 2011 Nov 10;9:193. doi: 10.1186/1479-5876-9-193.

PMID:
22071168
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment.

Massoner P, Ladurner Rennau M, Heidegger I, Kloss-Brandstätter A, Summerer M, Reichhart E, Schäfer G, Klocker H.

Am J Pathol. 2011 Dec;179(6):2905-19. doi: 10.1016/j.ajpath.2011.08.026. Epub 2011 Oct 6.

PMID:
21983635
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.

Kerick M, Isau M, Timmermann B, Sültmann H, Herwig R, Krobitsch S, Schaefer G, Verdorfer I, Bartsch G, Klocker H, Lehrach H, Schweiger MR.

BMC Med Genomics. 2011 Sep 29;4:68. doi: 10.1186/1755-8794-4-68.

PMID:
21958464
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008.

Oberaigner W, Siebert U, Horninger W, Klocker H, Bektic J, Schäfer G, Frauscher F, Schennach H, Bartsch G.

Int J Public Health. 2012 Feb;57(1):57-62. doi: 10.1007/s00038-011-0266-4. Epub 2011 Jun 17.

PMID:
21681451
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.

Kloss-Brandstätter A, Schäfer G, Erhart G, Hüttenhofer A, Coassin S, Seifarth C, Summerer M, Bektic J, Klocker H, Kronenberg F.

Am J Hum Genet. 2010 Dec 10;87(6):802-12. doi: 10.1016/j.ajhg.2010.11.001.

PMID:
21129724
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk